SCHEMBL29586720

SCHEMBL29586720

COS(=O)(=O)[O-].C[N+](C)(C)c1cccc(OC(=O)N2CCCCC2)c1

nearest known ligand 0.62

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE known ✓ P22303 6/20 0.62
▸ BCHE P06276 4/20 0.62
▸ GAA P10253 2/20 0.51
▸ TSHR P16473 2/20 0.49
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ MAPT P10636 3/20 0.47
▸ HTT P42858 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ LMNA P02545 4/20 0.46
▸ NPSR1 Q6W5P4 2/20 0.45
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ ATM Q13315 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ ADORA2A P29274 1/20 0.43
▸ ADORA1 P30542 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Neostigmine SCHEMBL41903 0.77 ACHE (1.00) ACHEBCHEGAATSHRMEN1
SCHEMBL29402628 0.74 ACHE (0.69) ACHEBCHEMEN1KMT2ALMNA
SCHEMBL29409592 0.74 ACHE (0.76) ACHEBCHESMN1; SMN2MEN1KMT2A
SCHEMBL29406757 0.73 ACHE (1.00) ACHEBCHEGAASMN1; SMN2MEN1
SCHEMBL29388689 0.73 ACHE (0.78) ACHEBCHEMEN1KMT2ALMNA
SCHEMBL28863714 0.73 GAA (0.68) GAATSHRSMN1; SMN2MEN1KMT2A
SCHEMBL7383611 0.71 GAA (0.62) BCHEGAATSHRSMN1; SMN2MEN1
SCHEMBL29363327 0.70 ACHE (0.71) ACHEBCHEMEN1KMT2ALMNA
SCHEMBL29352127 0.70 ACHE (0.67) ACHEBCHEGAASMN1; SMN2MEN1
Neostigmine SCHEMBL7105728 0.70 ACHE (0.87) ACHEBCHEGAATSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4453129-B1 ELECTRONIC DEVICES SAMSUNG ELECTRONICS CO LTD (KR) 2026-02-04 — — EP claimed
US-12522624-B2 Electroluminescent material and device thereof Beijing Summer Sprout Technology Co., Ltd. (CN) 2026-01-13 — — US claimed
CN-119156435-A Cyclic compounds for organic electroluminescent devices 默克专利有限公司 2024-12-17 — — CN claimed
WO-2024121084-A1 PREPARATION OF NITRILES MERCK PATENT GMBH (DE) 2024-06-13 — — WO claimed
US-20230301189-A1 ORGANIC ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-09-21 — — US claimed
US-20220274998-A1 ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-09-01 — — US claimed
US-20220231232-A1 ORGANIC ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-07-21 — — US claimed
US-20220177502-A1 ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-06-09 — — US claimed
EP-4736603-A1 DICYANOARYL COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES Merck Patent GmbH (DE) 2026-05-06 — — EP disclosed
EP-4724542-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES Merck Patent GmbH (DE) 2026-04-15 — — EP disclosed
EP-4078692-B1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2026-03-18 — — EP disclosed
EP-4453129-B1 ELECTRONIC DEVICES SAMSUNG ELECTRONICS CO LTD (KR) 2026-02-04 — — EP disclosed
EP-3658541-B1 SPIROBIFLUORENE DERIVATIVES FOR USE IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2025-11-26 — — EP disclosed
EP-4640022-A1 MATERIALS FOR ELECTRONIC DEVICES Merck Patent GmbH (DE) 2025-10-29 — — EP disclosed
EP-3679024-B1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2022-11-02 — — EP disclosed
US-20220325121-A1 MULTI-FLUID KITS FOR THREE-DIMENSIONAL PRINTING HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2022-10-13 — — US disclosed
WO-2022129116-A1 INDOLO[3.2.1-JK]CARBAZOLE-6-CARBONITRILE DERIVATIVES AS BLUE FLUORESCENT EMITTERS FOR USE IN OLEDS MERCK PATENT GMBH (DE) 2022-06-23 — — WO disclosed
WO-2022122682-A2 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-06-16 — — WO disclosed
CN-114381012-A Particle-dispersed polyimide precursor solution, method for producing porous polyimide film, and porous polyimide film 富士胶片商业创新有限公司 2022-04-22 — — CN disclosed
US-20220119596-A1 PARTICLE-DISPERSED POLYIMIDE PRECURSOR SOLUTION, METHOD FOR PRODUCING POROUS POLYIMIDE FILM, AND POROUS POLYIMIDE FILM FUJIFILM BUSINESS INNOVATION CORP. (JP) 2022-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220274998-A1 ELECTROLUMINESCENT DEVICE H1-2, H1-0, L1CAM ACHE 423/4885BCHE 2725/4885GAA 1796/4885
US-20220177502-A1 ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF IDO1, AZI2, YTHDF2 ACHE 321/4885BCHE 1626/4885GAA 3688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback